Just posted on Xitter:
----
Join us next week at #EAU24 in Paris! Abstract presentations will feature the Phase III ProstACT GLOBAL study of TLX591 for prostate cancer therapy, and the Phase II STARBURST study exploring TLX250-CDx theranostic utility beyond kidney cancer.
More: https://bit.ly/4aakz4R
----
Note that the dates are 5-8 April. My gut reaction is that these presentations wouldn't have new information, they're just reporting what we already know. But if they do, the AGM's on next Friday so that's a convenient place to discuss any interesting developments, eh?
Personally I regard STARBURST as one of the most significant trials the company is undertaking. According to clinicaltrials, it's going to recruit 100 patients and is due for primary completion at the end of 2025. I suppose they might have pretty pictures to show- would love it if they did- but I'm not expecting it.
- Forums
- ASX - By Stock
- Understanding Telix
Just posted on Xitter: ---- Join us next week at #EAU24 in...
- There are more pages in this discussion • 231 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$15.24 |
Change
0.440(2.97%) |
Mkt cap ! $5.036B |
Open | High | Low | Value | Volume |
$14.71 | $15.24 | $14.61 | $17.69M | 1.179M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2333 | $15.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.25 | 10000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2333 | 15.150 |
1 | 40 | 15.130 |
1 | 700 | 15.100 |
1 | 3080 | 15.000 |
1 | 75 | 14.950 |
Price($) | Vol. | No. |
---|---|---|
15.250 | 10000 | 2 |
15.300 | 836 | 1 |
15.400 | 4140 | 2 |
15.490 | 1680 | 2 |
15.500 | 1093 | 4 |
Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
Last
$15.21 |
  |
Change
0.440 ( 2.60 %) |
|||
Open | High | Low | Volume | ||
$14.73 | $15.24 | $14.62 | 327752 | ||
Last updated 15.59pm 03/05/2024 ? |
Featured News
TLX (ASX) Chart |